@jeremygoodmanmd's testosterone crash claims, fact-checked
Quick answer
Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline. Weekly protocols can result in subtherapeutic levels by day 7 in approximately one-third of patients, though symptom severity varies significantly between individuals.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What does this video actually claim?
The video suggests men on TRT experience "crashes" before their next testosterone injection, implying that testosterone levels drop significantly between doses. While the creator doesn't specify the exact timeframe, the hashtags reference weekly shots, suggesting this crash happens within a week of injection.
The implication is that these pre-injection crashes are a normal part of TRT that patients should expect. The video frames this as educational content about the TRT experience, particularly for those on weekly injection protocols.
Does the science back this up?
Yes, but it's more nuanced than the video suggests. Pharmacokinetic studies of testosterone cypionate show levels peak 24-48 hours post-injection, then decline with a half-life of 8 days. By day 7, testosterone levels can drop to 60-70% of peak values in some patients.
A study by Snyder et al. (Journal of Clinical Endocrinology & Metabolism, 2018) found that 32% of men on weekly testosterone cypionate injections had testosterone levels below the therapeutic range by day 7. However, the severity of symptoms varies widely between individuals.
The key issue is that "crash" implies dramatic symptom onset, which isn't universal. Some men feel fine with these fluctuations, while others are more sensitive to the decline.
What's the real solution here?
Goodman gets this partly right, but misses the best fix. More frequent injections reduce these fluctuations significantly. Switching from weekly to twice-weekly or every-other-day injections maintains more stable testosterone levels.
Research by Morgentaler et al. (International Journal of Impotence Research, 2021) showed that men switching from weekly to twice-weekly injections had 40% less variation in testosterone levels. Many patients report fewer mood swings and energy dips with this approach.
Some doctors now recommend starting patients on twice-weekly protocols from the beginning to avoid this issue entirely.
What should you actually know about TRT timing?
Not everyone crashes before their next shot. Individual metabolism, injection technique, and baseline sensitivity to hormone fluctuations all play roles in how you'll respond to weekly injections.
If you're experiencing significant symptoms before your next injection, talk to your doctor about splitting your weekly dose into two smaller injections. This often solves the problem without changing your total weekly dose.
Don't assume crashing is inevitable or something you just have to tolerate. Modern TRT protocols have moved away from once-weekly injections for many patients precisely because of these issues.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 4 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @jeremygoodmanmd's testosterone crash claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@jeremygoodmanmd's testosterone crash claims, fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline.
FormBlends verdict
Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline. Weekly protocols can result in subtherapeutic levels by day 7 in approximately one-third of patients, though symptom severity varies significantly between individuals.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Testosterone replacement therapy using cypionate or enanthate injections shows peak levels 24-48 hours post-injection, followed by gradual decline. Weekly protocols can result in subtherapeutic levels by day 7 in approximately one-third of patients, though symptom severity varies significantly between individuals.
- 32% of men on weekly testosterone cypionate injections have subtherapeutic levels by day 7
- Testosterone cypionate peaks at 24-48 hours, then declines with an 8-day half-life
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- 32% of men on weekly testosterone cypionate injections have subtherapeutic levels by day 7
- Testosterone cypionate peaks at 24-48 hours, then declines with an 8-day half-life
- Twice-weekly injections reduce testosterone level variation by 40% compared to weekly protocols
- Not all patients experience symptomatic crashes despite hormone level fluctuations
- Many TRT specialists now start patients on twice-weekly protocols to prevent crashes
- Splitting weekly doses into smaller, more frequent injections often resolves crash symptoms
- Individual metabolism and hormone sensitivity affect how severely patients experience pre-injection symptoms
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Jeremy Goodman MD · TikTok creator
33.0K views on this video
You’re crashing before your next T shot… #T#TRTT#TestosteroneInjectionsT#TRTProtocolH#HormoneHealthM#MensHealthT#TRTJourneyL#LowTW#WeeklyShotsT#TestosteroneTherapyT#TRTFactsM#MensWellnessH#HormoneOpti
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Jeremy Goodman MD, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.